tiprankstipranks
Aquestive Therapeutics, Inc. (AQST)
NASDAQ:AQST
US Market
AQST
Aquestive Therapeutics
RESEARCH TOOLSreports
Want to see AQST full AI Analyst Report?

Aquestive Therapeutics (AQST) Income Statement

2,472 Followers

Aquestive Therapeutics Income Statement

Last quarter (Q1 2026), Aquestive Therapeutics's total revenue was $14.45M, an increase of 65.67% from the same quarter last year. In Q1, Aquestive Therapeutics's net income was $-8.06M. See Aquestive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 44.55M$ 57.56M$ 50.58M$ 47.68M$ 50.83M
Gross Profit
$ 25.99M$ 39.69M$ 29.75M$ 28.29M$ 35.84M
Operating Expenses
$ 97.04M$ 70.46M$ 44.85M$ 70.36M$ 70.52M
Depreciation and Amortization
$ 559.00K$ 718.00K$ 1.34M$ 2.39M$ 2.96M
EBITDA
$ -70.49M$ -26.62M$ 1.18M$ -39.58M$ -45.11M
Operating Income
$ -71.05M$ -30.77M$ -15.10M$ -42.07M$ -34.68M
Other Income/Expenses
$ -12.73M$ -13.38M$ 7.48M$ -12.34M$ -35.86M
Pretax Income
$ -83.78M$ -44.15M$ -7.63M$ -54.41M$ -70.54M
Net Income
$ -83.78M$ -44.14M$ -7.87M$ -54.41M$ -70.54M
Per Share Metrics
Basic EPS
$ -0.76$ -0.51$ -0.13$ -1.12$ -1.85
Diluted EPS
$ -0.76$ -0.51$ -0.13$ -1.12$ -1.85
Weighted Average Shares Outstanding
 121.97M 86.73M 61.26M 48.73M 38.08M
Weighted Average Shares Outstanding (Diluted)
 121.97M 86.73M 61.26M 48.73M 38.08M
Currency in USD

Aquestive Therapeutics Earnings and Revenue History